Chlorpromazine-associated antiphospholipid antibody syndrome [3]

Annals of Pharmacotherapy

Volumn 41, Issue 3, 2007, Pages 528-

  Iyer, Harish V ^a,b   Moudgil, Harmesh ^a   Newman, Piers ^a   Srinivasan, Koottalai S ^a  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; RISPERIDONE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING TIME; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; EPILEPTIC STATE; FEMALE; GRAND MAL SEIZURE; HUMAN; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SIDE EFFECT; TONIC CLONIC SEIZURE; TREATMENT RESPONSE;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; FEMALE; HUMANS; NEUROTOXICITY SYNDROMES; PSYCHOTIC DISORDERS; SEIZURES;

EID: 34047193216     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H186     Document Type: Letter

References (5)

1. Asherson RA, Piette J-C. The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients. Lupus 1996;5:414-7.
2. Lillicrap MS, Wright G, Jones AC. Symptomatic antiphospholipid syndrome induced by chlorpromazine. Br J Rheumatol 1998;37:346-7.
3. Canoso RT, Sise HS. Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Hematol 1982;13:121-9.
4. Ducloux D, Florea A, Fournier V, et al. Inferior vena cava thrombosis in a patient with chlorpromazine-induced anticardiolipin antibodies (letter). Nephrol Dial Transplant 1999;14:1335-61.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.